Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemay005 in Active Ankylosing Spondylitis
CTR20221214Phase 2Completed
- Sponsor
- Ganzhou Hemay Pharmaceutical Co., Ltd.
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mufemilast in ankylosing spondylitis (AS), sponsored by Ganzhou Hemay Pharmaceutical Co., Ltd.. Started Jun 2022; status: completed.
02
Drugs
mufemilast
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on CTR20221214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221214.